Association Study of Chemokine (C–C motif) Ligand 5 Gene Polymorphism and Papillary Thyroid Cancer

REFERENCES

• Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA. 2006;295:2164–2167.
   PubMed Web of Science ®Google Scholar
• Goldgar DE, Easton DF, Cannon-Albright LA, Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst. 1994;86:1600–1608.
   PubMed Web of Science ®Google Scholar
• Czene K, Lichtenstein P, Hemminki K. Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database. Int J Cancer. 2002;99:260–266.
   PubMed Web of Science ®Google Scholar
• Canzian F, Amati P, Harach HR, A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2. Am J Hum Genet. 1998;63:1743–1748.
   PubMed Web of Science ®Google Scholar
• McKay JD, Lesueur F, Jonard L, Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21. Am J Hum Genet. 2001;69:440–446.
   PubMed Web of Science ®Google Scholar
• Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357:539–545.
   PubMed Web of Science ®Google Scholar
• Ben-Baruch A. The multifaceted roles of chemokines in malignancy. Cancer Metastasis Rev. 2006;25:357–371.
   PubMed Web of Science ®Google Scholar
• Conti I, Rollins BJ. CCL2 (monocyte chemoattractant protein-1) and cancer. Semin Cancer Biol. 2004;14:149–154.
   PubMed Web of Science ®Google Scholar
• Strieter RM, Burdick MD, Mestas J, Cancer CXC chemokine networks and tumour angiogenesis. Eur J Cancer. 2006;42:768–778.
   PubMed Web of Science ®Google Scholar
• Zlotnik A. Involvement of chemokine receptors in organ-specific metastasis. Contrib Microbiol. 2006;13:191–199.
   PubMedGoogle Scholar
• Manes S, Mira E, Colomer R, CCR5 expression influences the progression of human breast cancer in a p53-dependent manner. J Exp Med. 2003;198:1381–1389.
   PubMed Web of Science ®Google Scholar
• de la Rosa G, Longo N, Rodriguez-Fernandez JL, Migration of human blood dendritic cells across endothelial cell monolayers: adhesion molecules and chemokines involved in subset-specific transmigration. J Leukoc Biol. 2003;73:639–649.
   PubMed Web of Science ®Google Scholar
• Roth SJ, Carr MW, Springer TA. C-C chemokines, but not the C-X-C chemokines interleukin-8 and interferon-gamma inducible protein-10, stimulate transendothelial chemotaxis of T lymphocytes. Eur J Immunol. 1995;25:3482–3488.
   PubMed Web of Science ®Google Scholar
• Schall TJ, Bacon K, Toy KJ, Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature. 1990;347:669–671.
   PubMed Web of Science ®Google Scholar
• Hizawa N, Yamaguchi E, Konno S, A functional polymorphism in the RANTES gene promoter is associated with the development of late-onset asthma. Am J Respir Crit Care Med. 2002;166:686–690.
   PubMed Web of Science ®Google Scholar
• Nakajima K, Tanaka Y, Nomiyama T, RANTES promoter genotype is associated with diabetic nephropathy in type 2 diabetic subjects. Diabetes Care. 2003;26:892– 898.
   PubMed Web of Science ®Google Scholar
• Nickel RG, Casolaro V, Wahn U, Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES. J Immunol. 2000;164:1612–1616.
   PubMed Web of Science ®Google Scholar
• Liu H, Chao D, Nakayama EE, Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci U S A. 1999;96:4581–4585.
   PubMed Web of Science ®Google Scholar
• McDermott DH, Beecroft MJ, Kleeberger CA, Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study. AIDS. 2000;14:2671–2678.
   PubMed Web of Science ®Google Scholar
• Luboshits G, Shina S, Kaplan O, Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma. Cancer Res. 1999;59:4681–4687.
   PubMed Web of Science ®Google Scholar
• Niwa Y, Akamatsu H, Niwa H, Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer. Clin Cancer Res. 2001;7:285–289.
   PubMed Web of Science ®Google Scholar
• Yaal-Hahoshen N, Shina S, Leider-Trejo L, The chemokine CCL5 as a potential prognostic factor predicting disease progression in stage II breast cancer patients. Clin Cancer Res. 2006;12:4474–4480.
   PubMed Web of Science ®Google Scholar
• Saenz-Lopez P, Carretero R, Cozar JM, Genetic polymorphisms of RANTES, IL1-A, MCP-1 and TNF-A genes in patients with prostate cancer. BMC Cancer. 2008;8:382.
   PubMed Web of Science ®Google Scholar
• Weng CJ, Chien MH, Lin CW, Effect of CC chemokine ligand 5 and CC chemokine receptor 5 genes polymorphisms on the risk and clinicopathological development of oral cancer. Oral Oncol. 2010;46:767–772.
   PubMed Web of Science ®Google Scholar
• Gerard C, Rollins BJ. Chemokines and disease. Nat Immunol. 2001;2:108–115.
   PubMed Web of Science ®Google Scholar
• Mashino K, Sadanaga N, Yamaguchi H, Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma. Cancer Res. 2002;62:2937–2941.
   PubMed Web of Science ®Google Scholar
• Muller A, Homey B, Soto H, Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001;410:50–56.
   PubMed Web of Science ®Google Scholar
• Yasumoto K, Koizumi K, Kawashima A, Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer. Cancer Res. 2006;66:2181–2187.
   PubMed Web of Science ®Google Scholar
• Gonzalez HE, Leiva A, Tobar H, Altered chemokine receptor expression in papillary thyroid cancer. Thyroid. 2009;19:957–965.
   PubMed Web of Science ®Google Scholar
• Kalinski P, Nakamura Y, Watchmaker P, Helper roles of NK and CD8+ T cells in the induction of tumor immunity. Polarized dendritic cells as cancer vaccines. Immunol Res. 2006;36:137–146.
   PubMed Web of Science ®Google Scholar
• Tsukishiro S, Suzumori N, Nishikawa H, Elevated serum RANTES levels in patients with ovarian cancer correlate with the extent of the disorder. Gynecol Oncol. 2006;102:542–545.
   PubMed Web of Science ®Google Scholar
• Vaday GG, Peehl DM, Kadam PA, Expression of CCL5 (RANTES) and CCR5 in prostate cancer. Prostate. 2006;66:124–134.
   PubMed Web of Science ®Google Scholar
• Kondo T, Ito F, Nakazawa H, High expression of chemokine gene as a favorable prognostic factor in renal cell carcinoma. J Urol. 2004;171:2171–2175.
   PubMed Web of Science ®Google Scholar
• Moran CJ, Arenberg DA, Huang CC, RANTES expression is a predictor of survival in stage I lung adenocarcinoma. Clin Cancer Res. 2002;8:3803–3812.
   PubMed Web of Science ®Google Scholar
• Mule JJ, Custer M, Averbook B, RANTES secretion by gene-modified tumor cells results in loss of tumorigenicity in vivo: role of immune cell subpopulations. Hum Gene Ther. 1996;7:1545–1553.
   PubMed Web of Science ®Google Scholar
• Duell EJ, Casella DP, Burk RD, Inflammation, genetic polymorphisms in proinflammatory genes TNF-A, RANTES, and CCR5, and risk of pancreatic adenocarcinoma. Cancer Epidemiol Biomarkers Prev. 2006;15:726–731.
   PubMed Web of Science ®Google Scholar
• Bai B, Tanaka K, Tazawa T, Association between RANTES promoter polymorphism -401A and enhanced RANTES production in atopic dermatitis patients. J Dermatol Sci. 2005;39:189–191.
   PubMed Web of Science ®Google Scholar
• Liou JM, Lin JT, Huang SP, RANTES-403 polymorphism is associated with reduced risk of gastric cancer in women. J Gastroenterol. 2008;43:115–123.
   PubMed Web of Science ®Google Scholar